Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia (Q45279504)

11 December 2017

Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia (English)

1 reference

11 December 2017

0 references

0 references

1 reference

4

Younsuck Koh

1 reference

11 December 2017

3

Chae-Man Lim

1 reference

11 December 2017

Eun Young Choi

1

1 reference

11 December 2017

Jin Won Huh

2

1 reference

11 December 2017

Sung-Han Kim

5

1 reference

11 December 2017

Sang-Ho Choi

6

1 reference

11 December 2017

Yang Soo Kim

7

1 reference

11 December 2017

Mi-Na Kim

8

1 reference

11 December 2017

Sang-Bum Hong

9

1 reference

11 December 2017

21 January 2011

1 reference

11 December 2017

Intensive Care Medicine

1 reference

11 December 2017

37

1 reference

11 December 2017

639-647

1 reference

11 December 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s00134-011-2130-7

11 December 2017

0 references

cites work

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003.

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

Ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

Penetration of vancomycin into human lung tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

A mouse peritonitis model for the study of glycopeptide efficacy in GISA infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2130-7

Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia

21 January 2018

1 reference

12 December 2020

Point: Vancomycin is not obsolete for the treatment of infection caused by methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05

1 reference

12 December 2020

Rifampicin as an adjunct to vancomycin therapy in MRSA septicaemia in burns

1 reference

12 December 2020

Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia

1 reference

12 December 2020

Could de-escalation of antibiotic therapy be feasible even for documented methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia?

1 reference

12 December 2020

Staphylococcus aureus resistant to vancomycin--United States, 2002.

1 reference

12 December 2020

Antibiotic therapy of methicillin-resistant Staphylococcus aureus in critical care

1 reference

12 December 2020

10.1007/S00134-011-2130-7

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

0 references

1 reference